VKZ-28982-68841
2 vaccinations
2 coded responses
12 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 427 / KY
- Registered
- 2021-06-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-20
Dose 1 — Pfizer-BioNTech
-
2021-06-10
Registered in v-safe
-
2021-06-10
Dose 2 — Pfizer-BioNTech
-
2021-06-10
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: Good · Site: PainFree text: Post 12 hours since 2nd vaccine and no symptoms yetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
- 2021-06-13
- 2021-06-14
- 2021-06-16
- 2021-06-20
- 2021-06-24
- 2021-07-04
- 2021-07-08
-
2021-07-17
Survey response — day 35, dose 2MedDRA: Sinusitis, Upper respiratory tract infection — Feeling: FairFree text: Fighting sinus infection/upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
- 2021-07-22
- 2021-12-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-20 | Pfizer-BioNTech | |
| 2 | 2021-06-10 | Pfizer-BioNTech |
Free text
Release 9 — day 0, dose 2
Systemic reaction (other): Post 12 hours since 2nd vaccine and no symptoms yet
Release 9 — day 35, dose 2
Symptoms: Fighting sinus infection/upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinusitis | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release